Recent News

Source: The Wall Street Journal

Our progress toward recursive self-improvement, and its implications.

Organizations that deploy AI agents without observability processes and tools in place are disasters waiting to happen, some experts say.

Source: The New York Times

Source: Axios

The latest from Google I/O: See how we’re helping you get more done with Gemini.

Source: The Wall Street Journal

OpenEvidence, an AI-powered medical search tool, has become a fast friend to America’s doctors and is now used by nearly two-thirds of physicians.

Source: The Economist

Source: The Information

Source: Bloomberg

The former PepsiCo CEO says everyone—from CEOs to entry-level workers—has to “go back to being a student” in the age of AI.

Source: The New York Times

Source: The Information

We’ve raised Claude's usage limits and agreed a new compute partnership with SpaceX that will substantially increase our capacity in the near term.

Source: Anthropic

The agreement calls for AI developers to share models with reduced or removed safeguards to evaluate national security-related capabilities and risks.

The restructuring is aimed at addressing market volatility and increasing the use of AI tools to improve efficiency.

Amazon has so far kept its Rufus AI shopping assistant largely separate from its main commerce search bar. But the retail giant is leaving the door open to adding AI commentary to search results, bringing browsing and researching more seamlessly into the buying process. That could mean hybrid ...

The Trump administration, which took a noninterventionist approach to artificial intelligence, is now discussing imposing oversight on A.I. models before they are made publicly available.

Leading with the concept of the agentic enterprise, Governance Intelligence’s latest briefing highlighted a f

Yale's Jeffrey Sonnenfeld and colleagues argue that Claude Mythos will break enterprise deployment in ways that cannot be undone—without key fixes.

As Anthropic’s sales explode, straining the servers it uses, the company is considering adding another source of AI server chips in addition to existing suppliers Google, Amazon and Nvidia. The maker of Claude has recently been in talks with London-based startup Fractile to buy its inference ...

Source: Anthropic

Music is evolving, and so are the ways you discover and connect with artists. In the AI era, it’s more important than ever to be able to trust the authenticity of the music you listen to. At Spotify, our focus is providing you with more context about artists and their music, so you can build...

OpenAI is launching additional opt-in protections for ChatGPT accounts. The new security initiative includes a new partnership with security key provider Yubico.

Depreciation charges are eating into earnings at Microsoft, Alphabet, Meta and Amazon.

Source: The Information

New AI tools help chairs and directors with prep and research but are unlikely to be granted a vote

Catch up on our biggest updates from this year’s Cloud Next, including Gemini Enterprise Agent Platform and our newest TPUs.

Major insurers including Berkshire Hathaway, Chubb and Travelers are taking steps to cut AI-related damages from corporate insurance policies, and U.S. state regulators are giving them the green light. Insurers are trying to get ahead of risks from companies that use generative artificial ...

Canadian AI startup Cohere is taking over Germany-based Aleph Alpha with support from Lidl’s owner, Schwarz Group. With the blessing of their governments, the companies intend to offer a sovereign alternative to enterprises in an AI landscape dominated by American players.

Cohere is acquiring Aleph Alpha in a deal aimed at customers uneasy about the dominance of American companies in artificial intelligence.

OpenAI has mapped out ambitious targets for its recently launched ChatGPT advertising business, telling investors it plans to hit around $2.4 billion in ad revenue this year and nearly $11 billion in 2027. An analysis by The Information’s Deep Research shows there are still significant hurdles ...

OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries, joining a field of growing interest for tech companies eager to prove AI can pave the way for more scientific breakthroughs.